![Bruno Ohana](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Bruno Ohana is the founder of Biologit.
He held the title of Chief Technology Officer & Director at Biologit.
Aktive Positionen von Bruno Ohana
Unternehmen | Position | Beginn |
---|---|---|
biologit
![]() biologit Packaged SoftwareTechnology Services Biologit is an Irish technology company that specializes in AI development and dataset labeling for safety surveillance. The company is based in Dublin, Ireland and was founded by Naveen Basar and Bruno Ohana. Biologit combines expertise in pharmacovigilance, pharmaceuticals, biomedical, and artificial intelligence to deliver solutions that unlock safety and efficacy information faster, without compromising on quality, with the goal to keep patients safe. The company's flagship product, Biologit MLM-AI, is a scientific literature monitoring tool for human and veterinary pharmacovigilance, cosmetovigilance, and medical devices powered by artificial intelligence. The tool helps pharmacovigilance professionals focus on screening articles that matter. Nicole Baker has been the CEO since incorporation. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
biologit
![]() biologit Packaged SoftwareTechnology Services Biologit is an Irish technology company that specializes in AI development and dataset labeling for safety surveillance. The company is based in Dublin, Ireland and was founded by Naveen Basar and Bruno Ohana. Biologit combines expertise in pharmacovigilance, pharmaceuticals, biomedical, and artificial intelligence to deliver solutions that unlock safety and efficacy information faster, without compromising on quality, with the goal to keep patients safe. The company's flagship product, Biologit MLM-AI, is a scientific literature monitoring tool for human and veterinary pharmacovigilance, cosmetovigilance, and medical devices powered by artificial intelligence. The tool helps pharmacovigilance professionals focus on screening articles that matter. Nicole Baker has been the CEO since incorporation. | Technology Services |